Pfizer Inc. Overview
PFE market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
PFE price chart · 1M
- O
- 29.60
- H
- 29.60
- L
- 28.99
- C
- 29.19
- Vol
- 628,750.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $29.60
- Previous Close
- $29.39
- Day High
- $29.60
- Day Low
- $28.99
- 52 Week High
- $30.99
- 52 Week Low
- $22.42
- 7 Day Return
- -3.58%
- 30 Day Return
- +4.19%
- 90 Day Return
- +11.31%
- 1 Year Return
- +27.61%
- Daily Notional Volume
- $18.4M Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- 41.54 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.36 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.28 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 5.4% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 6.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $23.62 – $31.44 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $167.5B · P/B 1.64 · P/S 2.63.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured
Why Pfizer Believes It Can Be a Leader in the GLP-1 Market, Even Though Its Drug May Not Debut Until 2028The Motley Fool ·
BioNTech vs. Moderna: The COVID Vaccine Giants Are Entering a New Era. One Stock Could Have the Edge for 2027The Motley Fool ·
HALO Q3 Earnings Call Highlights Royalty Growth and Patent DisputeZacks Investment Research ·
NVAX Stock Falls 8% Despite Q3 Earnings & Sales Beat, Costs DeclineZacks Investment Research ·
DZ Bank Downgrades Pfizer to Hold From BuyFiscal.ai ·